SMTL ID : 9cus.1

BmrCD in the outward-facing conformation bound to Hoechsts

Coordinates

PDB Format Compare

Method

ELECTRON MICROSCOPY

Oligo State

hetero-1-1-mer

Ligands

2 x MG: MAGNESIUM ION(Non-covalent)

MG.1: 4 residues within 4Å: Chain A: T.400, Q.441, D.521 Ligands: ATP.2 1 PLIP interactions: 1 interactions with chain A Metal complexes: A:T.400 MG.14: 4 residues within 4Å: Chain A: G.499 Chain B: S.470, Q.511 Ligands: AOV.15 1 PLIP interactions: 1 interactions with chain B Metal complexes: B:S.470

1 x ATP: ADENOSINE-5'-TRIPHOSPHATE(Non-covalent)

ATP.2: 25 residues within 4Å: Chain A: E.132, Y.368, S.370, S.371, N.375, T.395, G.396, S.397, G.398, K.399, T.400, T.401, K.404, Y.410, Q.441, H.553 Chain B: K.551, S.565, T.566, L.567, S.568, S.569, G.570, E.571 Ligands: MG.1 21 PLIP interactions: 15 interactions with chain A, 6 interactions with chain B Hydrogen bonds: A:E.132, A:Y.368, A:G.396, A:S.397, A:G.398, A:K.399, A:T.400, A:T.401, A:Y.410, A:Q.441, B:K.551, B:T.566, B:S.568, B:S.568, B:G.570, B:E.571 Salt bridges: A:K.399, A:K.399, A:H.553 pi-Stacking: A:Y.368, A:Y.368

2 x HT1: 2'-(4-ETHOXYPHENYL)-5-(4-METHYL-1-PIPERAZINYL)-2,5'-BI-BENZIMIDAZOLE(Non-covalent)

HT1.3: 17 residues within 4Å: Chain A: V.51, N.52, E.55, M.56, P.59, W.100, D.163, F.167, T.170, S.302, V.305, Y.306, M.309 Chain B: H.338, N.342, R.345 Ligands: HT1.16 4 PLIP interactions: 4 interactions with chain A Hydrophobic interactions: A:E.55, A:V.305, A:Y.306 Salt bridges: A:D.163 HT1.16: 10 residues within 4Å: Chain A: V.301, V.305, M.309 Chain B: H.338, D.377, N.380, R.381, Q.384, T.387 Ligands: HT1.3 3 PLIP interactions: 1 interactions with chain A, 2 interactions with chain B Hydrophobic interactions: A:V.305, B:Q.384 Hydrogen bonds: B:D.377

20 x POV: (2S)-3-(hexadecanoyloxy)-2-[(9Z)-octadec-9-enoyloxy]propyl 2-(trimethylammonio)ethyl phosphate(Non-covalent)

POV.4: 7 residues within 4Å: Chain A: F.57, L.61, E.77, L.80, F.81, I.85, L.89 Ligand excluded by PLIP POV.5: 19 residues within 4Å: Chain A: T.90, A.91, Y.94, I.95, Y.98, F.99, H.102 Chain B: I.269, Y.273, Y.277, R.328, N.331, L.332, L.335, M.336, L.340, V.343 Ligands: POV.7, POV.19 Ligand excluded by PLIP POV.6: 16 residues within 4Å: Chain A: A.36, Y.37, L.39, R.40, I.43, L.47, A.50, F.87, V.88, A.91, A.92, I.95, M.96, F.99, Q.103 Ligands: POV.7 Ligand excluded by PLIP POV.7: 5 residues within 4Å: Chain A: I.95, F.99, Q.103 Ligands: POV.5, POV.6 Ligand excluded by PLIP POV.8: 4 residues within 4Å: Chain A: K.35, W.38, L.39 Ligands: POV.9 Ligand excluded by PLIP POV.9: 10 residues within 4Å: Chain A: L.27, K.28, G.31, F.34, K.35, I.158, L.161, V.162 Ligands: POV.8, POV.10 Ligand excluded by PLIP POV.10: 9 residues within 4Å: Chain A: F.24, S.25, K.28, K.29, S.199, S.203, Q.325, N.328 Ligands: POV.9 Ligand excluded by PLIP POV.11: 6 residues within 4Å: Chain A: K.182, F.185, A.186, I.189, Y.285 Ligands: POV.13 Ligand excluded by PLIP POV.12: 4 residues within 4Å: Chain A: F.177, L.178, I.179, E.299 Ligand excluded by PLIP POV.13: 5 residues within 4Å: Chain A: Y.285, F.288, R.292 Ligands: POV.11, POV.26 Ligand excluded by PLIP POV.17: 6 residues within 4Å: Chain B: F.246, L.247, L.248, D.249, V.250, V.371 Ligand excluded by PLIP POV.18: 16 residues within 4Å: Chain B: M.1, I.3, G.4, L.7, W.8, A.11, L.223, Y.224, L.228, F.231, W.264, S.267, R.271, L.396, R.400 Ligands: POV.21 Ligand excluded by PLIP POV.19: 7 residues within 4Å: Chain B: R.272, Y.273, Y.276, Y.277, Y.324, R.328 Ligands: POV.5 Ligand excluded by PLIP POV.20: 17 residues within 4Å: Chain A: Y.201, Q.255, F.262, L.266, P.269, T.270, L.273 Chain B: K.16, L.17, T.20, V.164, F.165, Y.168, G.169, Y.172, L.173, M.176 Ligand excluded by PLIP POV.21: 11 residues within 4Å: Chain B: G.4, K.5, W.8, A.11, L.12, R.15, L.18, I.19, V.22, L.228 Ligands: POV.18 Ligand excluded by PLIP POV.22: 15 residues within 4Å: Chain B: T.26, G.30, L.33, T.34, F.37, K.40, I.236, F.239, G.240, T.243, A.244, L.247, L.248, Y.378 Ligands: POV.23 Ligand excluded by PLIP POV.23: 8 residues within 4Å: Chain B: T.34, F.37, I.38, K.41, D.44, L.155, L.159 Ligands: POV.22 Ligand excluded by PLIP POV.24: 3 residues within 4Å: Chain B: K.41, L.152, L.155 Ligand excluded by PLIP POV.25: 11 residues within 4Å: Chain B: Q.143, P.144, I.146, K.147, V.150, L.151, C.154, G.158, V.161, F.162 Ligands: POV.26 Ligand excluded by PLIP POV.26: 13 residues within 4Å: Chain A: L.280, I.281, G.284, Y.285, F.288, R.292 Chain B: F.139, Q.143, I.146, V.150, I.153 Ligands: POV.13, POV.25 Ligand excluded by PLIP

1 x AOV: ADP ORTHOVANADATE

AOV.15: 23 residues within 4Å: Chain A: M.481, L.482, V.495, A.496, L.497, S.498, G.499, G.500, Q.501, A.526 Chain B: Y.439, V.445, T.465, G.466, S.467, G.468, K.469, S.470, S.471, Q.511, E.592, H.623 Ligands: MG.14 22 PLIP interactions: 16 interactions with chain B, 6 interactions with chain A Hydrogen bonds: B:D.202, B:H.464, B:G.466, B:G.466, B:S.467, B:G.468, B:K.469, B:K.469, B:S.470, B:S.470, B:S.471, B:Q.511, B:H.623, A:S.498, A:G.499, A:G.500, A:Q.501, A:Q.501, A:A.526 Salt bridges: B:K.469 pi-Stacking: B:Y.439, B:Y.439

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Tang, Q. et al., Lipid-mediated mechanism of drug extrusion by a heterodimeric ABC exporter. Biorxiv (2025)

Release Date

2025-08-13

Peptides

Probable multidrug resistance ABC transporter ATP-binding/permease protein YheI: A
Probable multidrug resistance ABC transporter ATP-binding/permease protein YheH: B

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
C

B
D

Membrane

We predict this structure to be a membrane protein.
Show / Hide

Probable multidrug resistance ABC transporter ATP-binding/permease protein YheI

Probable multidrug resistance ABC transporter ATP-binding/permease protein YheH

Related Entries With Identical Sequence